- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03823235
Humidified Culture and Live Birth After ICSI
June 9, 2020 updated by: Muhammad Fawzy, Ibn Sina Hospital
Humidified Incubator Effect on Live Birth Rate After ICSI
Humidity for human embryo culture has been raised as essential with advantageous effect on clinical pregnancy and ongoing pregnancy after ICSI compared with a dry incubator.
Whether the deleterious effect of dry culture would have an extended effect reaches the live birth rate needs to be examined.
This RCT is to examine the effect of dry and humidified culture on live birth rates after ICSI.
Study Overview
Study Type
Interventional
Enrollment (Actual)
1837
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Assiut, Egypt
- Banon Assiut
-
Qena, Egypt, 123456
- Qena Fertility Center
-
Sohag, Egypt
- IbnSina IVF Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Women undergoing a first or second ICSI attempts
- Primary or secondary infertility with a BMI of < 31 kg/m2
- Duration of infertility of ≥ 18 months and normal baseline ultrasonography
- 18 to 40 years of age
- Tubal factor, male factor, polycystic ovary, unexplained infertility or combined factors
- Tubal factors
Exclusion Criteria:
- Surgically-retrieved, frozen-thawed and pinpoint sperm or globozoospermia
- Thin endometrium
- Uterine anomaly and adhesion
- Adenomyosis
- Submucous myoma
- Endometriosis
- Severe medical condition
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Culture of human embryo in non-humidified incubator
Embryo culture after in vitro fertilization in incubator with no humidity
|
humidifed or dry incubator
|
|
No Intervention: Culture of human embryo in humidified incubator
Embryo culture after in vitro fertilization in incubator with humidity
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Live birth rate
Time Frame: 30 weeks
|
Viable neonate after 30 weeks of gestation per initiated cycle
|
30 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cumulative live birth rate
Time Frame: One year
|
Viable neonate after 30 weeks of gestation after one fresh and/or one frozen-warmed transfer per initiated cycle
|
One year
|
|
Ongoing pregnancy rate
Time Frame: 12 weeks of gestation
|
Continued pregnancy after 12 weeks of gestation per initiated cycle
|
12 weeks of gestation
|
|
Cumulative ongoing pregnancy rate
Time Frame: 12 weeks of gestation
|
Continued pregnancy after 12 weeks of gestation per initiated cycle within one year of randomization
|
12 weeks of gestation
|
|
Clinical pregnancy rate
Time Frame: 7 weeks of gestation
|
Ultrasound detect heartbeat after 7 weeks of gestation per initiated cycle
|
7 weeks of gestation
|
|
Cumulative clinical pregnancy rate
Time Frame: 7 weeks of gestation
|
Ultrasound detect heartbeat after 7 weeks of gestation per initiated cycle within one year of randomization
|
7 weeks of gestation
|
|
Implantation rate
Time Frame: 7 weeks of gestation
|
Number of sacs with a heartbeat per number of embryo transferred
|
7 weeks of gestation
|
|
Cumulative implantation rate
Time Frame: 7 weeks of gestation
|
Number of sacs with a heartbeat per number of embryo transferred within one year of randomization
|
7 weeks of gestation
|
|
Ongoing implantation rate
Time Frame: 12 weeks of gestation
|
Number of sacs with a heartbeat per number of embryo transferred
|
12 weeks of gestation
|
|
Cumulative ongoing implantation rate
Time Frame: 12 weeks of gestation
|
Number of sacs with a heartbeat per number of embryo transferred within one year of randomization
|
12 weeks of gestation
|
|
Preterm birth rate
Time Frame: 37 weeks
|
number of babies born before 37 weeks of gestation per total birth
|
37 weeks
|
|
Very preterm birth
Time Frame: 32 weeks
|
number of babies born before 32 weeks of gestation per total birth
|
32 weeks
|
|
Low birth weight rate
Time Frame: 40 weeks of gestation
|
number of babies with < 2500 gm per total birth
|
40 weeks of gestation
|
|
Fertilization rate
Time Frame: 6 days of culture
|
fertilized oocytes with two pronuclei per Metaphase II injected
|
6 days of culture
|
|
Cleavage rate
Time Frame: 6 days of culture
|
Cleaved embryo per fertilized oocyte
|
6 days of culture
|
|
Rate of high-quality day-3 embryos
Time Frame: 6 days of culture
|
Embryos with seven or eight blastomeres of appropriate-size, and < 10% fragmentation by volume per fertilized oocyte
|
6 days of culture
|
|
Blastocyst formation rate
Time Frame: 6 days of culture
|
Formed blastocyst on day 5/6 from fertilized oocytes
|
6 days of culture
|
|
Rate of high-quality blastocyst
Time Frame: 6 days of culture
|
Blastocysts ≥ 3.1.1
grade per fertilized oocyte
|
6 days of culture
|
|
Rate of utilizable blastocyst
Time Frame: 6 days of culture
|
Transferred and cryopreserved blastocysts from fertilized oocytes
|
6 days of culture
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2019
Primary Completion (Actual)
March 27, 2020
Study Completion (Actual)
March 27, 2020
Study Registration Dates
First Submitted
January 27, 2019
First Submitted That Met QC Criteria
January 29, 2019
First Posted (Actual)
January 30, 2019
Study Record Updates
Last Update Posted (Actual)
June 11, 2020
Last Update Submitted That Met QC Criteria
June 9, 2020
Last Verified
June 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IbnSina-Humidity
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infertility
-
Assuta Hospital SystemsMaccabi Healthcare Services, IsraelCompletedInfertility, Female Infertility, Male InfertilityIsrael
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedPregnancy | Male Infertility | Female InfertilityNetherlands
-
Sapientiae InstituteTerminated
-
Esraa Gamal AhmedAin Shams Maternity HospitalUnknownUnexplained Female Infertility
-
King's College LondonNot yet recruitingInfertility | Infertility, Female | Infertility Unexplained | Infertility of Tubal Origin
-
University of WashingtonEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedMale Infertility, AzoospermiaUnited States
-
Pacific Fertility CenterTerminatedPrimary Female Infertility | Secondary Female Infertility
-
Gazi UniversityCompletedMale Infertility | Unexplained Infertility
-
Viable BiosciencesEnrolling by invitationInfertility (IVF Patients) | Infertility Assisted Reproductive TechnologyUnited States
-
Wake Forest University Health SciencesWithdrawnUterine Diseases | Endometriosis | Infertility Unexplained | Endometrial Diseases | Infertility; Female, NonimplantationUnited States
Clinical Trials on Human embryo culture
-
Bruce Shapiro M.D.Withdrawn
-
Federal University of Minas GeraisCompleted
-
University Hospital, BordeauxProgramme Hospitalier de Recherche Clinique Inter-Régionale (PHRC-I)Active, not recruiting
-
National Foundation for Fertility ResearchCompletedInfertility | Reproductive Techniques, AssistedUnited States
-
University Hospital, GasthuisbergCompleted
-
Federal University of São PauloIncept BiosystemsUnknown
-
The First Affiliated Hospital with Nanjing Medical...RecruitingFertility Issues | Embryo Culture | Blastocyst IVFChina
-
Weill Medical College of Cornell UniversityVitrolifeTerminatedInfertilityUnited States
-
Texas Health ResourcesCompletedInfertility | In Vitro Fertilization | Pregnancy Outcome, Live BirthUnited States
-
Reproductive & Genetic Hospital of CITIC-XiangyaUnknown